Fluorine in PDB 1hbj: X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline
Enzymatic activity of X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline
All present enzymatic activity of X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline:
3.1.1.7;
Protein crystallography data
The structure of X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline, PDB code: 1hbj
was solved by
H.M.Greenblatt,
G.Kryger,
T.L.Lewis,
C.Doucet,
R.Viner,
I.Silman,
J.L.Sussman,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.31 /
2.50
|
Space group
|
P 31 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
112.332,
112.332,
137.073,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
18.3 /
21.4
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline
(pdb code 1hbj). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline, PDB code: 1hbj:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 1hbj
Go back to
Fluorine Binding Sites List in 1hbj
Fluorine binding site 1 out
of 4 in the X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1539
b:30.4
occ:1.00
|
F23
|
A:FBQ1539
|
0.0
|
30.4
|
1.0
|
C22
|
A:FBQ1539
|
1.4
|
28.9
|
1.0
|
F24
|
A:FBQ1539
|
2.3
|
27.9
|
1.0
|
F25
|
A:FBQ1539
|
2.3
|
27.2
|
1.0
|
C21
|
A:FBQ1539
|
2.5
|
27.2
|
1.0
|
OG
|
A:SER200
|
2.9
|
27.8
|
1.0
|
CH2
|
A:TRP233
|
2.9
|
24.2
|
1.0
|
O26
|
A:FBQ1539
|
2.9
|
26.5
|
1.0
|
CZ3
|
A:TRP233
|
3.0
|
26.7
|
1.0
|
CZ2
|
A:TRP233
|
3.3
|
24.6
|
1.0
|
N
|
A:ALA201
|
3.4
|
24.1
|
1.0
|
CE3
|
A:TRP233
|
3.4
|
25.5
|
1.0
|
CE2
|
A:TRP233
|
3.7
|
26.4
|
1.0
|
C17
|
A:FBQ1539
|
3.7
|
27.5
|
1.0
|
CD2
|
A:TRP233
|
3.8
|
25.2
|
1.0
|
CA
|
A:GLY119
|
3.8
|
27.2
|
1.0
|
CE2
|
A:PHE290
|
3.9
|
25.2
|
1.0
|
C
|
A:SER200
|
3.9
|
25.7
|
1.0
|
CA
|
A:ALA201
|
3.9
|
26.4
|
1.0
|
CB
|
A:SER200
|
4.0
|
26.4
|
1.0
|
N
|
A:GLY119
|
4.0
|
27.0
|
1.0
|
CB
|
A:ALA201
|
4.1
|
26.0
|
1.0
|
O
|
A:HOH2148
|
4.1
|
30.2
|
1.0
|
CA
|
A:SER200
|
4.3
|
26.5
|
1.0
|
CE1
|
A:PHE288
|
4.3
|
24.3
|
1.0
|
CZ
|
A:PHE290
|
4.4
|
25.5
|
1.0
|
C16
|
A:FBQ1539
|
4.5
|
28.6
|
1.0
|
C18
|
A:FBQ1539
|
4.6
|
27.5
|
1.0
|
NE1
|
A:TRP233
|
4.7
|
25.3
|
1.0
|
O
|
A:SER200
|
4.7
|
24.2
|
1.0
|
CD2
|
A:PHE290
|
4.8
|
25.0
|
1.0
|
CG
|
A:TRP233
|
4.8
|
24.9
|
1.0
|
C
|
A:GLY119
|
4.9
|
26.8
|
1.0
|
CZ
|
A:PHE288
|
5.0
|
24.5
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 1hbj
Go back to
Fluorine Binding Sites List in 1hbj
Fluorine binding site 2 out
of 4 in the X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1539
b:27.9
occ:1.00
|
F24
|
A:FBQ1539
|
0.0
|
27.9
|
1.0
|
C22
|
A:FBQ1539
|
1.4
|
28.9
|
1.0
|
F25
|
A:FBQ1539
|
2.2
|
27.2
|
1.0
|
F23
|
A:FBQ1539
|
2.3
|
30.4
|
1.0
|
C21
|
A:FBQ1539
|
2.4
|
27.2
|
1.0
|
C17
|
A:FBQ1539
|
2.7
|
27.5
|
1.0
|
C16
|
A:FBQ1539
|
2.9
|
28.6
|
1.0
|
O26
|
A:FBQ1539
|
3.0
|
26.5
|
1.0
|
CA
|
A:GLY119
|
3.1
|
27.2
|
1.0
|
CZ
|
A:PHE290
|
3.2
|
25.5
|
1.0
|
N
|
A:GLY119
|
3.2
|
27.0
|
1.0
|
CE2
|
A:PHE290
|
3.3
|
25.2
|
1.0
|
OG
|
A:SER200
|
3.5
|
27.8
|
1.0
|
CZ
|
A:PHE331
|
3.7
|
28.1
|
1.0
|
C18
|
A:FBQ1539
|
3.8
|
27.5
|
1.0
|
C15
|
A:FBQ1539
|
3.9
|
30.7
|
1.0
|
CE1
|
A:PHE290
|
4.1
|
26.9
|
1.0
|
CE1
|
A:PHE331
|
4.2
|
26.6
|
1.0
|
CD2
|
A:PHE290
|
4.3
|
25.0
|
1.0
|
C
|
A:GLY118
|
4.3
|
28.6
|
1.0
|
CE1
|
A:PHE288
|
4.4
|
24.3
|
1.0
|
C
|
A:GLY119
|
4.5
|
26.8
|
1.0
|
C19
|
A:FBQ1539
|
4.7
|
28.4
|
1.0
|
CE2
|
A:PHE331
|
4.7
|
27.8
|
1.0
|
C20
|
A:FBQ1539
|
4.7
|
29.6
|
1.0
|
CB
|
A:SER200
|
4.8
|
26.4
|
1.0
|
C14
|
A:FBQ1539
|
4.8
|
33.1
|
1.0
|
CE2
|
A:TYR121
|
4.9
|
26.7
|
1.0
|
CD1
|
A:PHE290
|
4.9
|
27.1
|
1.0
|
N
|
A:ALA201
|
4.9
|
24.1
|
1.0
|
CZ3
|
A:TRP233
|
4.9
|
26.7
|
1.0
|
CE3
|
A:TRP233
|
5.0
|
25.5
|
1.0
|
CA
|
A:GLY118
|
5.0
|
26.1
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 1hbj
Go back to
Fluorine Binding Sites List in 1hbj
Fluorine binding site 3 out
of 4 in the X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1539
b:27.2
occ:1.00
|
F25
|
A:FBQ1539
|
0.0
|
27.2
|
1.0
|
C22
|
A:FBQ1539
|
1.4
|
28.9
|
1.0
|
F24
|
A:FBQ1539
|
2.2
|
27.9
|
1.0
|
F23
|
A:FBQ1539
|
2.3
|
30.4
|
1.0
|
C21
|
A:FBQ1539
|
2.4
|
27.2
|
1.0
|
OG
|
A:SER200
|
2.7
|
27.8
|
1.0
|
C17
|
A:FBQ1539
|
2.8
|
27.5
|
1.0
|
O
|
A:HOH2148
|
3.0
|
30.2
|
1.0
|
C18
|
A:FBQ1539
|
3.0
|
27.5
|
1.0
|
CE1
|
A:PHE288
|
3.1
|
24.3
|
1.0
|
CZ
|
A:PHE288
|
3.3
|
24.5
|
1.0
|
CE1
|
A:PHE331
|
3.5
|
26.6
|
1.0
|
C16
|
A:FBQ1539
|
3.7
|
28.6
|
1.0
|
O26
|
A:FBQ1539
|
3.8
|
26.5
|
1.0
|
CZ
|
A:PHE331
|
3.8
|
28.1
|
1.0
|
C19
|
A:FBQ1539
|
4.1
|
28.4
|
1.0
|
CB
|
A:SER200
|
4.1
|
26.4
|
1.0
|
NE2
|
A:HIS440
|
4.2
|
38.7
|
1.0
|
CZ
|
A:PHE290
|
4.2
|
25.5
|
1.0
|
CD1
|
A:PHE288
|
4.3
|
25.0
|
1.0
|
CE2
|
A:PHE290
|
4.4
|
25.2
|
1.0
|
CZ2
|
A:TRP233
|
4.4
|
24.6
|
1.0
|
CE2
|
A:PHE288
|
4.5
|
23.1
|
1.0
|
CE2
|
A:TRP233
|
4.5
|
26.4
|
1.0
|
C15
|
A:FBQ1539
|
4.6
|
30.7
|
1.0
|
CE1
|
A:HIS440
|
4.7
|
39.6
|
1.0
|
CH2
|
A:TRP233
|
4.7
|
24.2
|
1.0
|
CD1
|
A:PHE331
|
4.7
|
25.3
|
1.0
|
C20
|
A:FBQ1539
|
4.8
|
29.6
|
1.0
|
CA
|
A:SER200
|
4.8
|
26.5
|
1.0
|
CD2
|
A:HIS440
|
4.9
|
37.7
|
1.0
|
NE1
|
A:TRP233
|
4.9
|
25.3
|
1.0
|
CD2
|
A:TRP233
|
4.9
|
25.2
|
1.0
|
N
|
A:ALA201
|
5.0
|
24.1
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 1hbj
Go back to
Fluorine Binding Sites List in 1hbj
Fluorine binding site 4 out
of 4 in the X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of X-Ray Crystal Structure of Complex Between Torpedo Californica Ache and A Reversible Inhibitor, 4-Amino-5-Fluoro-2-Methyl-3-(3- Trifluoroacetylbenzylthiomethyl)Quinoline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1539
b:34.4
occ:1.00
|
F27
|
A:FBQ1539
|
0.0
|
34.4
|
1.0
|
C7
|
A:FBQ1539
|
1.4
|
35.0
|
1.0
|
C8
|
A:FBQ1539
|
2.4
|
34.3
|
1.0
|
C3
|
A:FBQ1539
|
2.5
|
33.6
|
1.0
|
N11
|
A:FBQ1539
|
2.7
|
32.9
|
1.0
|
CE2
|
A:PHE330
|
2.9
|
26.2
|
1.0
|
C4
|
A:FBQ1539
|
3.0
|
32.5
|
1.0
|
CD1
|
A:TRP84
|
3.3
|
30.0
|
1.0
|
O
|
A:HOH2018
|
3.5
|
40.0
|
1.0
|
CZ
|
A:PHE330
|
3.6
|
30.7
|
1.0
|
CD2
|
A:PHE330
|
3.6
|
28.2
|
1.0
|
CZ2
|
A:TRP432
|
3.6
|
28.5
|
1.0
|
C9
|
A:FBQ1539
|
3.7
|
34.9
|
1.0
|
NE1
|
A:TRP84
|
3.7
|
28.2
|
1.0
|
C2
|
A:FBQ1539
|
3.8
|
33.1
|
1.0
|
O
|
A:GLY80
|
4.0
|
34.0
|
1.0
|
CG
|
A:TRP84
|
4.1
|
29.8
|
1.0
|
CA
|
A:SER81
|
4.2
|
36.7
|
1.0
|
CH2
|
A:TRP432
|
4.2
|
30.4
|
1.0
|
C10
|
A:FBQ1539
|
4.2
|
34.0
|
1.0
|
C5
|
A:FBQ1539
|
4.4
|
34.5
|
1.0
|
OH
|
A:TYR334
|
4.5
|
26.5
|
1.0
|
CB
|
A:SER81
|
4.5
|
34.5
|
1.0
|
CE2
|
A:TRP432
|
4.6
|
27.6
|
1.0
|
CE2
|
A:TRP84
|
4.6
|
29.8
|
1.0
|
O
|
A:SER81
|
4.7
|
38.4
|
1.0
|
CE1
|
A:PHE330
|
4.7
|
29.6
|
1.0
|
CG
|
A:PHE330
|
4.7
|
29.6
|
1.0
|
CB
|
A:TRP84
|
4.8
|
31.3
|
1.0
|
C
|
A:GLY80
|
4.8
|
35.5
|
1.0
|
CD2
|
A:TRP84
|
4.9
|
29.6
|
1.0
|
N1
|
A:FBQ1539
|
4.9
|
32.4
|
1.0
|
OD2
|
A:ASP72
|
4.9
|
37.2
|
1.0
|
N
|
A:SER81
|
4.9
|
34.9
|
1.0
|
NE1
|
A:TRP432
|
4.9
|
26.8
|
1.0
|
|
Reference:
C.Doucet-Personeni,
P.D.Bentley,
R.J.Fletcher,
A.Kinkaid,
G.Kryger,
B.Pirard,
A.Taylor,
R.Taylor,
J.Taylor,
R.Viner,
I.Silman,
J.L.Sussman,
H.M.Greenblatt,
T.L.Lewis.
A Structure-Based Design Approach to the Development of Novel, Reversible Ache Inhibitors J.Med.Chem. V. 44 3203 2001.
ISSN: ISSN 0022-2623
PubMed: 11563919
DOI: 10.1021/JM010826R
Page generated: Wed Jul 31 11:30:37 2024
|